Published in Am J Gastroenterol on August 28, 2012
Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease | NCT05185609
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One (2015) 3.37
The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol (2015) 2.51
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol (2015) 2.35
Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in Japan. Am J Gastroenterol (2014) 2.35
Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol (2014) 2.11
Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. Am J Gastroenterol (2016) 1.43
Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol (2014) 1.15
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol (2015) 0.98
Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol (2013) 0.94
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy. Med Sci Monit (2014) 0.91
Common Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.88
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol (2015) 0.87
IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol (2015) 0.86
Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol (2014) 0.84
Relationship between the exocrine and endocrine pancreas after acute pancreatitis. World J Gastroenterol (2014) 0.82
Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol (2014) 0.82
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res (2016) 0.82
The role of mucosal healing in the treatment of patients with inflammatory bowel disease. Curr Treat Options Gastroenterol (2014) 0.81
Can fecal calprotectin better stratify Crohn's disease activity index? Ann Gastroenterol (2015) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. Am J Gastroenterol (2015) 0.80
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis (2014) 0.80
Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease. J Neurogastroenterol Motil (2016) 0.80
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
The analysis of factors associated with progression of isolated terminal ileal lesions. PLoS One (2014) 0.79
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother (2014) 0.78
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78
Behavioral and molecular processing of visceral pain in the brain of mice: impact of colitis and psychological stress. Front Behav Neurosci (2015) 0.78
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation. Am J Gastroenterol (2016) 0.78
Advances in IBS 2016: A Review of Current and Emerging Data. Gastroenterol Hepatol (N Y) (2016) 0.78
Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis (2017) 0.77
Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J (2016) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care. World J Gastroenterol (2013) 0.77
Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.77
"Irritable bowel symptoms" in inflammatory bowel disease: diagnostic uncertainty meets pathological reality. Am J Gastroenterol (2012) 0.77
"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion. World J Gastrointest Pathophysiol (2014) 0.76
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J Gastroenterol (2016) 0.76
Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases-A Prospective Study on Incidence and Severity. J Crohns Colitis (2015) 0.75
Role of environmental pollution in irritable bowel syndrome. World J Gastroenterol (2015) 0.75
Irritable bowel syndrome: current and emerging treatment options. P T (2014) 0.75
Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach? Clin Transl Gastroenterol (2015) 0.75
Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease. J Crohns Colitis (2015) 0.75
Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide. Inflamm Bowel Dis (2017) 0.75
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol (2016) 0.75
Effects of Guchang Capsule on Dextran Sulphate Sodium-Induced Experimental Ulcerative Colitis in Mice. Evid Based Complement Alternat Med (2016) 0.75
Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.75
Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey. Ann Gastroenterol (2016) 0.75
Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity. World J Gastroenterol (2016) 0.75
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Identification of alverine and benfluorex as HNF4α activators. ACS Chem Biol (2013) 0.75
Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil (2016) 0.75
Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. Children (Basel) (2017) 0.75
Psychological Factors May Play an Important Role in Pediatric Crohn's Disease Symptoms and Disability. J Pediatr (2017) 0.75
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterol (2016) 0.75
Psychological Distress and Quality of Life in Pediatric Crohn Disease: Impact of Pain and Disease State. J Pediatr Gastroenterol Nutr (2017) 0.75
Monitoring-Based Model for Personalizing the Clinical Process of Crohn's Disease. Sensors (Basel) (2017) 0.75
Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet. Dig Dis Sci (2017) 0.75
Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis. PLoS One (2017) 0.75
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol (2012) 4.78
Functional Dyspepsia. N Engl J Med (2015) 3.66
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol (2011) 2.19
Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies. Am J Gastroenterol (2013) 2.18
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
Initial management of dyspepsia in primary care: an evidence-based approach. Br J Gen Pract (2013) 1.90
Direction of the brain--gut pathway in functional gastrointestinal disorders. Gut (2012) 1.43
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease. Gut (2010) 1.41
Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.32
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 1.24
Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Am J Gastroenterol (2011) 1.09
Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.06
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis (2013) 1.04
Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol (2012) 0.96
Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol (2015) 0.89
Diagnosis and treatment of irritable bowel syndrome. Discov Med (2011) 0.88
Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same. Gastroenterol Clin North Am (2011) 0.82
Redundant data in the meta-analysis on Helicobacter pylori eradication. Ann Intern Med (2009) 0.82
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol (2011) 0.80
Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience. World J Gastroenterol (2013) 0.79
Efficacy of traditional chinese medicine in functional constipation. Am J Gastroenterol (2011) 0.78
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2009) 0.78
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience. J Crohns Colitis (2011) 0.78
Long-term efficacy and safety of azathioprine in ulcerative colitis. J Crohns Colitis (2015) 0.77
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Ther Adv Chronic Dis (2013) 0.76
"Power" of selective serotonin reuptake inhibitors in irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 0.76
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience. J Crohns Colitis (2011) 0.75
Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome. Am J Gastroenterol (2011) 0.75
Overlap among the functional gastrointestinal disorders. Am J Gastroenterol (2010) 0.75
Don't forget about constipation with opioid treatment of chronic non-cancer pain. BMJ (2013) 0.75
Bran and irritable bowels. Bran's deleterious effects: much ado about nothing. BMJ (2009) 0.75
Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated? Dig Dis Sci (2010) 0.75
Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome. Expert Rev Anti Infect Ther (2010) 0.75
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice. Gastroenterology (2009) 0.75
Clopidogrel with or without omeprazole in coronary disease. N Engl J Med (2011) 0.75
Treatment of chronic gastro-oesophageal reflux disease. BMJ (2009) 0.75
Functional Dyspepsia. N Engl J Med (2016) 0.75
Treatment of Helicobacter pylori in Latin America. Lancet (2012) 0.75
Reply to Machicado JD, Villafuerte-Galvez J, Marcos LA, Prevalence of irritable bowel syndrome in South America. Clin Gastroenterol Hepatol (2012) 0.75
GERD: Is laparoscopic surgery cost-effective? Nat Rev Gastroenterol Hepatol (2009) 0.75
Disease activity and venous thromboembolism in inflammatory bowel disease. Lancet (2010) 0.75
VSL#3 and remission in active ulcerative colitis: larger studies required. Am J Gastroenterol (2011) 0.75
Helicobacter pylori eradication. Lancet (2011) 0.75
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation? Inflamm Bowel Dis (2016) 0.75
A patient with chronic diarrhea of unknown cause. Clin Gastroenterol Hepatol (2012) 0.75
Faecal microbiota transplantation for <em>Clostridium difficile</em>-associated diarrhoea: a systematic review of randomised controlled trials. Med J Aust (2017) 0.75
The Glasgow Prognostic Score at the Time of Palliative Esophageal Stent Insertion is a Predictive Factor of 30-Day Mortality and Overall Survival. J Clin Gastroenterol (2016) 0.75
Symbiotics in irritable bowel syndrome--better than probiotics alone? Curr Opin Clin Nutr Metab Care (2015) 0.75
Constipation in adults. BMJ Clin Evid (2015) 0.75